ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
$0.94+0.03 (+3.30%)
Close on Nov 16, 2026Market cap $25.06MP/E –Yield –
ABVC BioPharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
ABVC BioPharma's price to book ratio was 2.5× on Nov 10, 2026, against 282.7× a year earlier. Over the last 5 years it ranged from 0.6× to 282.7×, with a median of 4.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 2.5× | −219.7 |
| 2025 | Dec 31, 2025 | 222.2× | +217.6 |
| 2024 | Dec 31, 2024 | 4.6× | +4.0 |
| 2023 | Dec 29, 2023 | 0.6× | −2.8 |
| 2022 | Dec 30, 2022 | 3.4× | −7.6 |
| 2021 | Dec 31, 2021 | 11.0× | −73.8 |
| 2020 | Jan 31, 2020 | 84.8× | −43.0 |
| 2019 | Dec 31, 2019 | 127.8× | – |
See a number that looks wrong?